Literature DB >> 8125745

Effect of melanocyte stimulating hormone on human cultured choroidal melanocytes, uveal melanoma cells, and retinal epithelial cells.

T Goodall1, J A Buffey, I G Rennie, M Benson, M A Parsons, M K Faulkner, S MacNeil.   

Abstract

PURPOSE: To establish methodology for the culture of human choroidal melanocytes to compare their responsiveness to melanocyte stimulating hormone (MSH) with that of their transformed melanoma counterparts and with that of the retinal epithelial cell.
METHODS: Choroidal melanocytes from the choroid of eyes enucleated for the presence of malignant melanoma were cultured in MCDB 153 medium supplemented with insulin, transferrin, hydrocortisone, glutamine, nystatin, vitamin E, phorbol myristate acetate, bovine hypothalamic extract, cholera toxin, and chelexed fetal calf serum.
RESULTS: High yields of pure spindle-shaped bipolar melanocytes were obtained with a doubling time of 3 to 4 days in nine consecutive eyes. Cells continued to divide after 4 months in culture. In contrast, uveal malignant melanoma cells grew rapidly in a relatively simple medium of Ham's F12:DMEM (1:1) supplemented with fetal calf serum, insulin, transferrin and glutamine. This medium was unable to support choroidal melanocytes. Choroidal melanocytes were DOPA-positive with appreciable tyrosinase activity that significantly increased with treatment with MSH. MSH also significantly altered the size, local density, and distribution of primary and mature melanosomes of ocular melanocytes. In contrast, uveal melanoma cells had a low level of tyrosinase activity and failed to respond to MSH with either an increase in enzyme activity or melanosome size. Retinal epithelial cells failed to show significant tyrosinase activity under the conditions studied or any increase in melanosome size in response to MSH.
CONCLUSION: Ocular melanocytes show evidence of regulation by MSH and a range of mitogenic stimuli unlike the transformed melanoma cells, implying a loss of regulatory control in the latter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125745

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Mechanism related to reduction of intraocular pressure by melanocortins in rabbits.

Authors:  N Naveh; A Kaplan-Messas; J Marshall
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

Review 2.  Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors:  E Zamir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

3.  Serum-free cultivation of adult normal human choroidal melanocytes.

Authors:  Monika Valtink; Katrin Engelmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-26       Impact factor: 3.117

Review 4.  Is Uveal Melanoma a Hormonally Sensitive Cancer? A Review of the Impact of Sex Hormones and Pregnancy on Uveal Melanoma.

Authors:  Manisha Miller; Lynn Schoenfield; Mohamed Abdel-Rahman; Colleen M Cebulla
Journal:  Ocul Oncol Pathol       Date:  2021-04-22

5.  Investigation of the role of signal transduction in attachment of ocular melanoma cells to matrix proteins: inhibition of attachment by calmodulin antagonists including tamoxifen.

Authors:  S Mac Neil; M Wagner; I G Rennie
Journal:  Clin Exp Metastasis       Date:  1994-11       Impact factor: 5.150

6.  Melanocortins applied intravitreally delay retinal dystrophy in Royal College of Surgeons rats.

Authors:  Nava Naveh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-30       Impact factor: 3.117

7.  Tamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin.

Authors:  L O Dewhurst; J W Gee; I G Rennie; S MacNeil
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.